Literature DB >> 11756619

Persistent movement disorders following Japanese encephalitis.

U A Murgod1, U B Muthane, V Ravi, S Radhesh, A Desai.   

Abstract

The authors report on movement disorders that persist for a long duration following Japanese encephalitis (JE). Fifteen patients with diagnosed JE were followed up after an interval of 3 to 5 years. Of the four patients with a movement disorder, two were children with severe generalized dystonia in whom MRI revealed bilateral thalamic lesions. The two adult patients had parkinsonism. MRI in both adult patients showed lesions confined to the substantia nigra. Viral antibody and antigen were absent in the CSF of all patients.

Entities:  

Mesh:

Year:  2001        PMID: 11756619     DOI: 10.1212/wnl.57.12.2313

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

2.  A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.

Authors:  Na Li; Zhe-Rui Zhang; Ya-Nan Zhang; Jing Liu; Cheng-Lin Deng; Pei-Yong Shi; Zhi-Ming Yuan; Han-Qing Ye; Bo Zhang
Journal:  NPJ Vaccines       Date:  2020-08-05       Impact factor: 7.344

3.  Substantia nigra depigmentation and exposure to encephalitis lethargica.

Authors:  Nawaz Hack; Gregory A Jicha; Annalisa Abell; Dawson Dean; Jerrold L Vitek; Joseph R Berger
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

4.  NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER.

Authors:  May H Han; Melanie Walker; Joseph R Zunt
Journal:  Continuum (Minneap Minn)       Date:  2006-04

Review 5.  Recent advances in Japanese encephalitis.

Authors:  Tom Solomon
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

6.  Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Susan L Hills; Emmanuel B Walter; Robert L Atmar; Marc Fischer
Journal:  MMWR Recomm Rep       Date:  2019-07-19

7.  Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2.

Authors:  Shi-Hua Li; Xiao-Feng Li; Hui Zhao; Yong-Qiang Deng; Xue-Dong Yu; Shun-Ya Zhu; Tao Jiang; Qing Ye; E-De Qin; Cheng-Feng Qin
Journal:  Virol J       Date:  2013-02-26       Impact factor: 4.099

Review 8.  Pathogenesis of flavivirus encephalitis.

Authors:  Thomas J Chambers; Michael S Diamond
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

9.  A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.

Authors:  Na Li; Zhe-Rui Zhang; Ya-Nan Zhang; Jing Liu; Cheng-Lin Deng; Pei-Yong Shi; Zhi-Ming Yuan; Han-Qing Ye; Bo Zhang
Journal:  NPJ Vaccines       Date:  2020-08-05       Impact factor: 7.344

10.  Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.

Authors:  Byron E Martina; Penelopie Koraka; Petra van den Doel; Geert van Amerongen; Guus F Rimmelzwaan; Albert D M E Osterhaus
Journal:  Vaccine       Date:  2007-11-20       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.